- Home
- ABEO vs FRST Comparison
ABEO vs FRST Comparison
Compare ABEO & FRST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEO
- FRST
- Stock Information
- Founded
- ABEO 1974
- FRST 2004
- Country
- ABEO United States
- FRST United States
- Employees
- ABEO N/A
- FRST N/A
- Industry
- ABEO Biotechnology: Pharmaceutical Preparations
- FRST Major Banks
- Sector
- ABEO Health Care
- FRST Finance
- Exchange
- ABEO Nasdaq
- FRST Nasdaq
- Market Cap
- ABEO 289.2M
- FRST 273.3M
- IPO Year
- ABEO 1980
- FRST 2006
- Fundamental
- Price
- ABEO $5.26
- FRST $10.64
- Analyst Decision
- ABEO Strong Buy
- FRST Buy
- Analyst Count
- ABEO 6
- FRST 1
- Target Price
- ABEO $18.17
- FRST $420.00
- AVG Volume (30 Days)
- ABEO 1.1M
- FRST 82.5K
- Earning Date
- ABEO 11-13-2025
- FRST 10-23-2025
- Dividend Yield
- ABEO N/A
- FRST 3.76%
- EPS Growth
- ABEO N/A
- FRST N/A
- EPS
- ABEO 0.99
- FRST 0.11
- Revenue
- ABEO $400,000.00
- FRST $127,561,000.00
- Revenue This Year
- ABEO N/A
- FRST $13.42
- Revenue Next Year
- ABEO $324.71
- FRST $13.48
- P/E Ratio
- ABEO $5.31
- FRST $95.86
- Revenue Growth
- ABEO N/A
- FRST 19.27
- 52 Week Low
- ABEO $3.93
- FRST $7.59
- 52 Week High
- ABEO $7.54
- FRST $12.95
- Technical
- Relative Strength Index (RSI)
- ABEO 31.86
- FRST 45.25
- Support Level
- ABEO $5.19
- FRST $10.27
- Resistance Level
- ABEO $5.49
- FRST $10.78
- Average True Range (ATR)
- ABEO 0.19
- FRST 0.22
- MACD
- ABEO 0.01
- FRST -0.01
- Stochastic Oscillator
- ABEO 12.84
- FRST 39.66
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
About FRST Primis Financial Corp.
Primis Financial Corp is the bank holding company for Primis Bank, providing financial services to individuals and small and medium-sized businesses. Primis Bank offers a wide range of commercial banking services, It focuses on making loans secured mainly by commercial real estate and other types of secured and unsecured commercial loans to small and medium-sized businesses in several industries, as well as loans to individuals for a variety of purposes. Primis Bank offers a broad range of deposit products, including checking (NOW), savings, money market accounts, and certificates of deposit. Its operating segments are Primis Mortgage, Primis Bank, and Other.